Mexican Chamber of Deputies Approves New Legislation to Ban the Illicit Use of E-Cigarettes

Dec.04.2024
Mexican Chamber of Deputies Approves New Legislation to Ban the Illicit Use of E-Cigarettes
The Mexican Chamber of Deputies has passed a constitutional amendment to prohibit the illicit use of fentanyl and e-cigarette products, and will adjust the relevant legal framework to align with the new law.

According to El Mexicano, on December 3rd, the Mexican Chamber of Deputies passed a bill with 410 votes in favor, 24 against, and zero abstentions, which prohibits the illegal use of products such as fentanyl and e-cigarettes in the constitution.

 

This reform is part of a package of 20 initiatives proposed by President Andrés Manuel López Obrador. The move comes after the 2022 National Health and Nutrition Survey revealed that e-cigarette use among adolescents reached 2.6% of the reference population (approximately 500 individuals) and 1.5% of the adult population (around 300,000 individuals), contributing to negative health impacts.

 

The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) reported that in 2022, around five million people aged 12 to 65 had tried vaping devices, with 975,000 using them regularly.

 

In response to these figures, the approved reform adds provisions to Articles 4 and 5 of the Political Constitution of the United Mexican States, aimed at enhancing health protection. It establishes that "to ensure the right to health protection for individuals, the law will penalize any activity related to e-cigarettes, vaping devices, and other similar electronic systems or devices, as well as the production, distribution, and sale of toxic substances, chemical precursors, the illicit use of fentanyl, and other unauthorized synthetic drugs."

 

The amendment also prohibits professions, industries, internal and external commerce, employment, or any other activity related to these substances.

 

The law specifies the prohibition of the production, distribution, and sale of toxic substances, chemical precursors, and the illicit use of unauthorized synthetic drugs such as fentanyl and methamphetamines.

 

The reform stipulates that the Congress of the Union will have 180 days to harmonize existing legal frameworks with the decree's contents, and each of Mexico's 32 states must make the required regulatory adjustments within 365 days of the reform's publication.

 

The Plenary session clarified that no additional funds would be authorized for the implementation of this decree. All costs resulting from its enactment will be covered by the existing budgets of the responsible authorities for the current fiscal year.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Exclusive Interview with UK Brand PIXL: Disposable Ban Sparks “Pod System Opportunity” — High-Puff Refillable Vapes Become the New Must-Have
Exclusive Interview with UK Brand PIXL: Disposable Ban Sparks “Pod System Opportunity” — High-Puff Refillable Vapes Become the New Must-Have
Following the UK’s disposable vape ban, the market saw major shifts. PIXL quickly entered with a “2+10ml” high-puff pod system. At the Dubai expo, the brand highlighted its user-focused design, modular strategy, and noted how the ban is driving demand for compliant refillable products.
Jun.26 by 2FIRSTS.ai
U.S. FDA: Tobacco Product Listings Must Be Regularly Updated, June 30 Marks Key Deadline
U.S. FDA: Tobacco Product Listings Must Be Regularly Updated, June 30 Marks Key Deadline
The U.S. FDA requires all registered tobacco manufacturers to submit product listing change reports by June 30 and December 31 each year. This includes new product launches, product discontinuations, resumptions of production, and significant changes to product information. Reports can be submitted online through the next-generation Tobacco Registration and Listing Module (TRLM NG) system or by mailing paper forms.
Jun.25 by 2FIRSTS.ai
China Tobacco Deputy Administrator Liu Sanjiang Meets with BMJ CEO Huang Tianle
China Tobacco Deputy Administrator Liu Sanjiang Meets with BMJ CEO Huang Tianle
On July 15, Liu Sanjiang, Deputy Administrator of the State Tobacco Monopoly Administration, met with BMJ CEO Huang Tianle in Beijing for a cordial discussion. Heads of several departments from the administration also attended the meeting.
Jul.16 by 2FIRSTS.ai
Tobacco Growers Discuss Shared Challenges and Opportunities at ITGA Regional Meeting
Tobacco Growers Discuss Shared Challenges and Opportunities at ITGA Regional Meeting
The ITGA Americas meeting gathered growers and stakeholders from key regions to address climate impacts, rising production costs, and shifting global demand. 2Firsts was invited to attend, with Editor-in-Chief Taco Tuinstra reporting on-site.
Jun.04
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai
Altria Q2 2025: E-cigarette Unit Posts $108M Operating Loss; Nicotine Pouch on! Grows 26.5%
Altria Q2 2025: E-cigarette Unit Posts $108M Operating Loss; Nicotine Pouch on! Grows 26.5%
OCHA Group 2025 disclosed on July 30, 2025, Q2 net income of $6.102 billion, down 1.7% year-over-year, and adjusted diluted EPS of $1.44, up 8.3% year-over-year, while first-half net income of $11.361 billion was down 3.6% year-over-year, and adjusted diluted EPS of $2.67, up 7.2% year-over-year.
Jul.31 by 2FIRSTS.ai